The vital signs tracker developer has raised $13.5m in an oversubscribed round that included corporates Swiss Re and STMicroelectronics.

Novo, Johnson and Johnson, Eli Lilly and Novartis are all participants in the neurodegenerative disease drug developer's first funding round.

E-Scape Bio, a spinout of Gladstone Institutes, has achieved a final close of its series A thanks to commitments from Osage University Partners and several corporates.

New Oriental Education and Technology Group has participated in a round for Yamibuy, which sells Asian consumer items to North America-based customers.

Carmaker Toyota's research division has put $100m into a unit called Toyota AI Ventures and disclosed its first three portfolio companies.

Brandless, the developer of an online budget supermarket, has emerged from stealth with $50m, $35m of which came in a recently closed series B round.

The precision medicine company, set up by molecular biology company Qiagen and science park BioBay, will use the money to transition towards a full-fledged products company.

Tencent, URWork and Recruit all made strategic investments in an eight-figure renminbi round for Qualcomm-backed online ticketing platform Huodongxing.

The antibody replacement technology was co-developed by the California Institute of Technology.